Publications by authors named "Lee Finlan"

Claim this Profile
D
DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.
Ashley L Craig, Jitka Holcakova, Lee E Finlan, Marta Nekulova, Roman Hrstka

Mol Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Porin new light onto chromatin and nuclear organization.
Lee E Finlan, Wendy A Bickmore

Genome Biol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment to the nuclear periphery can alter expression of genes in human cells.
Lee E Finlan, Duncan Sproul, Inga Thomson, Shelagh Boyle, Elizabeth Kerr

PLoS Genet· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p63: the phantom of the tumor suppressor.
Lee E Finlan, Ted R Hupp

Cell Cycle· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK2-site phosphorylation of p53 is induced in DeltaNp63 expressing basal stem cells in UVB irradiated human skin.
Lee E Finlan, Rudolf Nenutil, Sally H Ibbotson, Borek Vojtesek, Ted R Hupp

Cell Cycle· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.
Harumi Shimizu, David Saliba, Maura Wallace, Lee Finlan, Patrick R R Langridge-Smith

Biochem J· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.
Lee Finlan, Ted R Hupp

J Biol Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling to p53: the use of phospho-specific antibodies to probe for in vivo kinase activation.
Ashley L Craig, Susan E Bray, Lee E Finlan, Neil M Kernohan, Ted R Hupp

Methods Mol Biol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
Michelle Ferguson, M Gloria Luciani, Lee Finlan, Elaine M Rankin, Sally Ibbotson

Cell Cycle· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis